The present Invention relates to Crystalline forms of n– {6 (2–hidroxipropan–2–il) –2– [2 - (methylsulfonyl) ethyl] –2h–indazol–5–il} –6– (trifluoromethyl) piridin–2–carboxamida, processes for its preparation.Pharmaceutical compositions that comprise and their use in the control of disorders.
展开▼